RETRACTED: Kinase inhibitors and airway inflammation
- 8 March 2006
- journal article
- retracted article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 533 (1-3), 118-132
- https://doi.org/10.1016/j.ejphar.2005.12.054
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- A selective novel low‐molecular‐weight inhibitor of IκB kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activityBritish Journal of Pharmacology, 2005
- Attenuation of Murine Collagen-Induced Arthritis by a Novel, Potent, Selective Small Molecule Inhibitor of IκB Kinase 2, TPCA-1 (2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), Occurs via Reduction of Proinflammatory Cytokines and Antigen-Induced T Cell ProliferationJournal of Pharmacology and Experimental Therapeutics, 2004
- Allergen-induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N-terminal kinaseBritish Journal of Pharmacology, 2003
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- The Orally Available Spleen Tyrosine Kinase Inhibitor 2-[7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide Dihydrochloride (BAY 61-3606) Blocks Antigen-Induced Airway Inflammation in RodentsThe Journal of pharmacology and experimental therapeutics, 2003
- Update on glucocorticoid action and resistanceJournal of Allergy and Clinical Immunology, 2003
- Increased expression of nuclear factor- B in bronchial biopsies from smokers and patients with COPDEuropean Respiratory Journal, 2002
- AsthmaThe New England Journal of Medicine, 2001
- Activation and Localization of Transcription Factor, Nuclear Factor- κ B, in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Direct interaction of Syk and Lyn protein tyrosine kinases in rat basophilic leukemia cells activated via type I Fcɛ receptorsEuropean Journal of Immunology, 1997